Perjeta: how long were the pivotal tox studies?

“tolerability and the 6-month (Q weekly dosing x 26 weeks) repeat-dose toxicity studies in cynomolgus monkeys.”

“Study title: Twenty-six week intravenous toxicity and toxicokinetic study with pertuzumab in cynomolgus monkeys with an 8-week recovery period”

“The purpose of this study was to evaluate multiple dose PK of pertuzumab in cynomolgus monkeys following IV administration once per week for 26 weeks.”